Pathology of AIHA, for neet pg 2026, cover everything that can come for this exam
autoimmune hemolytic anemia AIHA classification pathology warm cold antibody
AIHA Coombs test direct indirect antiglobulin hemolysis mechanism lab findings
warm AIHA IgG extravascular hemolysis spleen pathophysiology Fc receptor macrophage
cold agglutinin disease IgM complement intravascular hemolysis paroxysmal cold hemoglobinuria Donath-Landsteiner
| Type | Antibody | Ig Class | Optimal Reactivity Temp | Mechanism of Hemolysis |
|---|---|---|---|---|
| Warm AIHA | Warm antibody | IgG (rarely IgA) | 37°C | Extravascular (spleen) |
| Cold Agglutinin Disease (CAD) | Cold antibody | IgM | 0–4°C (reacts up to 30°C) | Extravascular (liver) + Intravascular |
| Paroxysmal Cold Hemoglobinuria (PCH) | Donath-Landsteiner Ab | IgG (biphasic) | Cold → 37°C | Intravascular (complement) |
| Drug-induced AIHA | Varies | IgG/IgM | Variable | Variable |
| Mixed AIHA | Both warm + cold | IgG + IgM | Both | Both |
Key point for MCQs: Warm AIHA → IgG → Spleen → Extravascular hemolysis → Microspherocytes
| Test | What it detects | Positive in |
|---|---|---|
| Direct Coombs (DAT) | Antibody/complement on patient's RBC | AIHA, HDN, drug-induced hemolysis |
| Indirect Coombs (IAT) | Antibody in patient's serum reacting with donor RBCs | Crossmatching, HDN screening |
| Phase | Temperature | Event |
|---|---|---|
| Cold phase (0–15°C) | Cold | IgG binds P antigen on RBC → fixes complement (C1–C3) |
| Warm phase (37°C) | Warm | Complement cascade completes → MAC → intravascular hemolysis |
| Mechanism | Prototype Drug | Antibody | DAT | Mechanism |
|---|---|---|---|---|
| Hapten/Drug adsorption | Penicillin (high dose) | IgG anti-drug | IgG positive | Drug binds RBC → IgG directed against drug-RBC complex → extravascular |
| Immune complex (Innocent bystander) | Quinidine, quinine, rifampicin | IgM or IgG | C3 positive | Drug-Ab complex adsorbs onto RBC → complement activation → intravascular |
| Autoantibody induction | Methyldopa (α-methyldopa) | IgG anti-Rh | IgG positive | Drug alters RBC surface → true autoantibody formed → indistinguishable from warm AIHA |
Methyldopa: 15–20% develop positive DAT; only 1% develop actual hemolysis. Antibody is directed at Rh antigens.
| Finding | Significance |
|---|---|
| Microspherocytes | Hallmark of warm AIHA (partial phagocytosis) |
| Polychromasia | Reticulocytosis (compensatory) |
| Agglutination of RBCs | Cold agglutinin disease |
| Nucleated RBCs | Severe hemolysis |
| Ghost cells / fragmented RBCs | NOT typical of AIHA (more TTP/HUS/DIC) |
| AIHA Type | IgG | C3 |
|---|---|---|
| Warm AIHA | ✅ Positive | ± |
| Cold Agglutinin Disease | ❌ Negative | ✅ Positive |
| PCH | Weakly + / ❌ | ✅ Positive |
| Drug (hapten) | ✅ Positive | ❌ |
| Drug (immune complex) | ❌ | ✅ Positive |
| Drug (methyldopa) | ✅ Positive | ❌ |
| Parameter | Finding |
|---|---|
| Hemoglobin | Low |
| MCV | Elevated (reticulocytes are large) |
| Reticulocyte count | High (reticulocytosis) |
| Peripheral smear | Spherocytes, polychromasia |
| Serum LDH | Elevated |
| Serum bilirubin (indirect) | Elevated |
| Serum haptoglobin | Low/absent (binds free Hb) |
| Urine urobilinogen | Elevated |
| Urine hemoglobin | Present only in intravascular hemolysis (PCH, severe CAD) |
| Urine hemosiderin | In chronic intravascular hemolysis |
| Bone marrow | Erythroid hyperplasia |
| Type | Treatment |
|---|---|
| Warm AIHA | Steroids (prednisolone 1 mg/kg) = first line; Rituximab, splenectomy |
| CAD | Avoid cold; Rituximab ± bendamustine; steroids ineffective |
| PCH | Treat underlying cause; avoid cold; usually self-limiting in children |
| Drug-induced | Stop the offending drug |
| Association | AIHA Type |
|---|---|
| SLE | Warm AIHA |
| CLL | Warm AIHA (most common secondary cause) |
| Mycoplasma pneumoniae | Cold Agglutinin (anti-I IgM) |
| EBV / Infectious Mononucleosis | Cold Agglutinin (anti-i IgM) |
| Waldenström macroglobulinemia | Cold Agglutinin (monoclonal IgM) |
| Syphilis (tertiary) | PCH (Donath-Landsteiner) |
| Post-viral in children | PCH |
| Methyldopa | Drug AIHA (autoantibody type) |
| Fludarabine | Warm AIHA |
| Evan's syndrome | Warm AIHA + Immune thrombocytopenia (ITP) |